project id: TCGA-STAD; case submitter id: TCGA-VQ-A94T; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.52; rna integrity number: 8.5; age at index: 73; days to birth: -26702; days to death: 342; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1938; year of death: 2011; age at diagnosis: 26702; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 888; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-VQ-A94T-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 1.0; percent necrosis: 5.0; percent neutrophil infiltration: 1.0; percent normal cells: 10.0; percent stromal cells: 10.0; percent tumor cells: 75.0; percent tumor nuclei: 90.0;